Stay updated on IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial

Sign up to get notified when there's something new on the IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-01T02:15:32.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    A sitewide NIH banner announces a transition to using “Super Intelligence” instead of “Artificial Intelligence” under Executive Order 14434.
    Difference
    0.7%
    Check dated 2026-10-25T02:16:17.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page footer now displays site revision v3.7.2 instead of v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-18T02:05:24.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The site footer identifies the ClinicalTrials.gov interface as revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-11T03:01:59.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The study record history remains unchanged, showing its version timeline and the sections updated in prior submissions.
    Difference
    0.1%
    Check dated 2026-10-04T02:32:05.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The record history now contains a new revision label v3.7.0, replacing the previous v3.6.6 entry and updating the version history.
    Difference
    0.1%
    Check dated 2026-09-20T01:12:13.000Z thumbnail image

Stay in the know with updates to IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial page.